Filter
45
Filtered Results: 45
Text search:
nanoparticles
Featured
Recommendations
9
New Publications
5
Language
Document type
Guidelines
14
Studies & Reports
13
No document type
10
Manuals
4
Fact sheets
4
Countries / Regions
Syria
3
Middle East and North Africa
3
Russia
3
Yemen
3
Ukraine
1
Global
1
Latin America and the Carribbean
1
Sudan
1
South Sudan
1
Authors & Publishers
Publication Years
Category
Countries
7
Clinical Guidelines
3
Pharmacy & Technologies
2
Capacity Building
1
Women & Child Health
1
Toolboxes
COVID-19
22
Ebola
6
Planetary Health
6
Pharmacy
3
Global Health Education
3
Rapid Response
2
AMR
2
HIV
1
TB
1
NTDs
1
Conflict
1
Zika
1
In this edition, the Antimicrobial Resistance chapter discusses the growing, dangerous trend of antimicrobial resistance and the potential catastrophic consequences on global health.
The Nanomaterials chapter talks about this relatively new technology and its potential impacts on the environment a...
9 Febr. 2022
The COVID Covovax™ (SIIPL) and Nuvaxovid™ (Novavax) vaccine explainer includes key vaccine specific information on the vaccine specific requirements.
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
10 December 2020
New England Journal of Medicine
April 9, 2021
DOI: 10.1056/NEJMoa2104840
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
orientaciones provisionales, 23 de diciembre de 2020
En este documento se resumen las recomendaciones de la OMS para utilizar de forma racional los equipos de protección personal (EPP) tanto en los centros sanitarioscomo en los domicilios, así como durante la manipulación...
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
This booklet presents key messages for action, summarized from a set of
chapters on different environmental health issues.
23 December 2020 This document summarizes WHO recommendations for the rational use of personal protective equipment (PPE) in health care settings and temporary strategies during acute supply shortages. This document also contains 2 Annex sections describing updated PPE use recommendations for health...
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
